First iPS Cell Trial for Heart Disease Raises Excitement, Concern
First iPS Cell Trial for Heart Disease Raises Excitement, Concern
Without knowing the cells’ mechanism of action, researchers question the best way to administer them to patients.
First iPS Cell Trial for Heart Disease Raises Excitement, Concern
First iPS Cell Trial for Heart Disease Raises Excitement, Concern

Without knowing the cells’ mechanism of action, researchers question the best way to administer them to patients.

Without knowing the cells’ mechanism of action, researchers question the best way to administer them to patients.

heart failure
Cardiac Cell Transplants Help Monkeys’ Hearts
Cardiac Cell Transplants Help Monkeys’ Hearts
Ashley Yeager | Jul 2, 2018
The organ’s blood-pumping capacity improved with the infusion of cells, a study shows.
Why Afternoon Open Heart Surgery Is Better for Patient Outcomes
Why Afternoon Open Heart Surgery Is Better for Patient Outcomes
Catherine Offord | Oct 27, 2017
Research in human patients and mice reveals the role of the circadian clock in the risk of heart damage at different times of day.
Image of the Day: Un-break My Heart
Image of the Day: Un-break My Heart
The Scientist Staff | Aug 8, 2017
A failing heart is easily distinguished from a healthy one by numerous tell-tale signs, including its slender, stretched-out walls, increased size, and pooled blood clots.
Heart’s Backup Pacemaker Mechanisms Identified
Heart’s Backup Pacemaker Mechanisms Identified
Diana Kwon | Jul 28, 2017
The sinoatrial node is home to multiple pacemakers that keep the heart beating if the main one falters.
The Fatty Acid–Ketone Switch
The Fatty Acid–Ketone Switch
Amanda B. Keener | Jun 1, 2016
In failing hearts, cardiomyocytes change their fuel preference.
In Failing Hearts, Cardiomyocytes Alter Metabolism
In Failing Hearts, Cardiomyocytes Alter Metabolism
Amanda B. Keener | Jun 1, 2016
While the heart cells normally burn fatty acids, when things go wrong ketones become the preferred fuel source.
Hearts in Hand
Hearts in Hand
The Scientist Staff | Jan 1, 2016
Texas Heart Institute heart surgeon Bud Frazier is a pioneer of heart transplant technologies.
If It Ain't Broke . . .
If It Ain't Broke . . .
Kerry Grens | Jan 1, 2016
Is there room to improve upon the tried-and-true, decades-old technology of artificial hearts?
Cell Transplants for Heart Questioned
Cell Transplants for Heart Questioned
Jef Akst | May 1, 2014
A report reveals that using bone marrow stem cells to treat heart disease is less promising than a decade of research has let on.